Forschungsinstitut für molekulare Pathologie Gesellschaft m.b.H.
Gesellschaft mit beschränkter Haftung (GmbH) · Wien, Austria · LEI 529900XIA762B58MYP48
LEI active
Summary
Forschungsinstitut für molekulare Pathologie Gesellschaft m.b.H. is registered in Austria and entered in the “Commercial Register (Firmenbuch)” under number 82531w. Its legal form is Gesellschaft mit beschränkter Haftung (GmbH) – private limited company (Austria). According to GLEIF, its ultimate parent is C.H. Boehringer Sohn AG & Co. KG (Germany), which is also its direct parent. That group has 41 subsidiaries with LEIs in 16 countries, 4 of them in Austria. The LEI was first issued on 24 Oct 2017 and the record was last updated on 11 Sep 2026; the next renewal is due by 24 Oct 2027.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | Gesellschaft mit beschränkter Haftung (GmbH) private limited company (Austria) |
|---|---|
| Register | Commercial Register (Firmenbuch) · Register website |
| Registration number | 82531w |
| Registration authority | Federal Ministry of Justice |
| Jurisdiction | Austria |
| Registered address | Campus-Vienna-Biocenter 1, 1030 Wien, Austria |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 2 Sep 1985 |
| LEI | 529900XIA762B58MYP48 |
| LEI status | active |
| LEI first issued | 24 Oct 2017 |
| LEI record last updated | 11 Sep 2026 |
| Next LEI renewal | 24 Oct 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Forschungsinstitut für molekulare Pathologie Gesellschaft m.b.H. this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | C.H. Boehringer Sohn AG & Co. KG | C.H. Boehringer Sohn AG & Co. KG |
| Accounting period | 1 Jan 2024 to 31 Dec 2024 | 1 Jan 2024 to 31 Dec 2024 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Relationship start | 4 Oct 2017 | 4 Oct 2017 |
| Recorded at GLEIF since | 29 Sep 2020 | 24 Oct 2017 |
| Last updated | 11 Sep 2026 | 11 Sep 2026 |
| Record status | current | current |
Other subsidiaries of the same direct parent (40)
- Boehringer Ingelheim Pharma Gesellschaft m.b.H. Austria
- Boehringer Ingelheim RCV GmbH & Co KG Austria
- Boehringer Ingelheim RCV Holding GmbH Austria
- AGC PHARMA CHEMICALS EUROPE S.L. Spain lapsed
- AMAL THERAPEUTICS SA Switzerland
- BIDACHEM S.P.A. Italy
- Boehringer Ingelheim Animal Health Denmark A/S Denmark
- Boehringer Ingelheim Animal Health International GmbH Germany
- Boehringer Ingelheim Animal Health Japan Holding GmbH Germany
- Boehringer Ingelheim Animal Health Participations GmbH Germany
- BOEHRINGER INGELHEIM ANIMAL HEALTH UK LIMITED United Kingdom
- Boehringer Ingelheim Animal Healts France France